Beauty

Shiseido to sell China Aupres subsidiary to IDG-led consortium

Naomi SekiguchiNovember 19, 20265 min read1 views

At a glance

  • The binding deal covers full ownership of Shiseido Liyuan Cosmetics and is expected to close between late 2026 and early 2027.
  • Shiseido has agreed to sell its Chinese Aupres-making subsidiary, Shiseido Liyuan Cosmetics, to an IDG Capital-led consortium, with closing expected in Q4 2026–Q1 2027 pending approvals. The move is part of its 2030 strategy to improve profitability and capital efficiency while retaining China support through licensing and transitional supply arrangements.
A split boardroom composition shows unbranded skincare bottles and a factory blueprint being separated toward a laboratory area.

Shiseido has signed a binding agreement to sell its Chinese subsidiary, Shiseido Liyuan Cosmetics (SLC), to an investor consortium led by Hong Kong-headquartered private equity firm IDG Capital. SLC makes and sells the Aupres brand in China, and the transaction transfers the entire company. Financial terms were not disclosed.

The deal is expected to close between the fourth quarter of 2026 and the first quarter of 2027, subject to regulatory approvals, including in China. Under the ownership structure, funds managed by IDG Capital will hold 95% of the equity through two special purpose vehicles. A limited partnership enterprise set up mainly by SLC's new management team will hold the remaining 5%.

Strategic rationale

Shiseido frames the divestment as part of its push to improve profitability and capital efficiency under its 2030 Medium-Term Strategy. The group said it wants to drive sustainable growth and strengthen competitiveness in China by focusing management resources on areas where it enjoys the greatest competitive advantage.

According to Shiseido, the sale sheds a business that requires continued investment in product innovation and digital capabilities. The company said the divestment allows it to concentrate on priority brands and higher-growth opportunities. It also described China as a strategically important and attractive, dynamic market where the competitive landscape continues to evolve amid rapid e-commerce expansion, changing consumer behavior and the emergence of diverse market participants.

Aupres history and handover

SLC was established in 1991 as a joint venture with Beijing Liyuan, a subsidiary of Yiqing Group owned by the Beijing Municipal Government. It has sold the C-beauty brand Aupres since 1994. With the joint venture agreement due to expire in December 2026, the parties agreed not to renew it. On September 1, 2026, Shiseido acquired Beijing Liyuan's 35% stake, giving it full ownership before the sale.

The transaction includes SLC's Beijing factory and production equipment. Shiseido said it believes independent operation under IDG will support SLC's sustainable growth and brand value. To ensure a smooth handover, Shiseido will license the intellectual property rights IDG needs to run the business.

For a specified period after the transfer, Shiseido will provide support on new product development, technical assistance for the stable supply of existing products, and continued supply of raw materials and selected products. The company said this transitional collaboration is intended to maintain SLC's innovation capabilities, product quality and business continuity.

Recent profit recovery

The divestment comes days after Shiseido reported a 124.3% jump in core operating profit for the third quarter of 2026, to ¥67.5 billion (US$422.13 million). The company attributed the recovery to restructuring, cost cuts and improved margins rather than strong product demand; like-for-like sales grew 0.7%.

Shiseido raised its full-year core operating profit forecast to ¥87 billion (US$546 million) from ¥59 billion (US$433 million) on the back of those results. The sale remains subject to approvals and is expected to close between the fourth quarter of 2026 and the first quarter of 2027.

Reported by Naomi Sekiguchi, Fragrance and Sensory Analyst.